Clinical Trial Update: A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea [Phase 3]

View source ↗

Summary

Phase 3 trial of Exodif for Clostridioides difficile infection-associated diarrhea was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Pseudomembranous Colitis

Drugs mentioned

• Exodif

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Enterocolitis, Pseudomembranous, Diarrhea | Phase 3 | Status: TERMINATED